Why Have Microrna Biomarkers Not Been Translated From Bench to Clinic?

Tehran University of Medical Sciences

Science Communicator Platform

Stay connected! Follow us on X network (Twitter):

Share By

Why Have Microrna Biomarkers Not Been Translated From Bench to Clinic? Publisher Pubmed

Saliminejad K¹ ; Khorram Khorshid HR² ; Ghaffari SH¹

Source: Future Oncology Published:2019

Abstract

[No abstract available]

Related Docs

View other Related Docs

1. Critical Considerations for Investigating Micrornas During Tumorigenesis: A Case Study in Conceptual and Contextual Nuances of Mir-211-5P in Melanoma, Epigenomes (2023)

2. An Overview of Micrornas: Biology, Functions, Therapeutics, and Analysis Methods, Journal of Cellular Physiology (2019)

3. Recent Advances on High-Efficiency of Micrornas in Different Types of Lung Cancer: A Comprehensive Review, Cancer Cell International (2023)

Experts (# of related papers)

View all Related Experts

Hamid Reza Mirzaei (2)

Seyed Hamidollah Ghaffari (2)

Other Related Docs

4. A Panel of Circulating Micrornas As a Potential Biomarker for the Early Detection of Gastric Cancer, Avicenna Journal of Medical Biotechnology (2022)

5. Exosomes and Micrornas in Biomedical Science, Synthesis Lectures on Biomedical Engineering (2022)

6. Gynecologic Cancers and Non-Coding Rnas: Epigenetic Regulators With Emerging Roles, Critical Reviews in Oncology/Hematology (2021)

7. Mir-495–3P As a Promising Tumor Suppressor in Human Cancers, Pathology Research and Practice (2023)

8. Circulating Tumor Dnas and Non-Coding Rnas As Potential Biomarkers for Hepatocellular Carcinoma Diagnosis, Prognosis and Response to Therapy, Hepatoma Research (2019)

9. The Significant Role of Micrornas in Gliomas Angiogenesis: A Particular Focus on Molecular Mechanisms and Opportunities for Clinical Application, Cellular and Molecular Neurobiology (2023)

Style	Citing Format
MLA	Saliminejad K, Khorram Khorshid HR, Ghaffari SH. "Why Have Microrna Biomarkers Not Been Translated From Bench to Clinic?." Future Oncology, vol. 15, no. 8, 2019, pp. 801-803.
APA	Saliminejad K, Khorram Khorshid HR, Ghaffari SH (2019). Why Have Microrna Biomarkers Not Been Translated From Bench to Clinic?. Future Oncology, 15(8), 801-803.
Chicago	Saliminejad K, Khorram Khorshid HR, Ghaffari SH. "Why Have Microrna Biomarkers Not Been Translated From Bench to Clinic?." Future Oncology 15, no. 8 (2019): 801-803.
Harvard	Saliminejad K, Khorram Khorshid HR, Ghaffari SH (2019) 'Why Have Microrna Biomarkers Not Been Translated From Bench to Clinic?', Future Oncology, 15(8), pp. 801-803.
Vancouver	Saliminejad K, Khorram Khorshid HR, Ghaffari SH. Why Have Microrna Biomarkers Not Been Translated From Bench to Clinic?. Future Oncology. 2019;15(8):801-803.
BibTex	@article{ author = {Saliminejad K and Khorram Khorshid HR and Ghaffari SH}, title = {Why Have Microrna Biomarkers Not Been Translated From Bench to Clinic?}, journal = {Future Oncology}, volume = {15}, number = {8}, pages = {801-803}, year = {2019} }
RIS	TY - JOUR AU - Saliminejad K AU - Khorram Khorshid HR AU - Ghaffari SH TI - Why Have Microrna Biomarkers Not Been Translated From Bench to Clinic? JO - Future Oncology VL - 15 IS - 8 SP - 801 EP - 803 PY - 2019 ER -